Westin Immunogenicity Seminar 2011

Tuesday, September 27, 2011

9:45 am – 6:10 pm

Kiri Room

The Westin Tokyo

1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan

Speakers:

Annie De Groot M.D.

Director and Professor, Institute of Immunology and Informatics,University of Rhode Island and CEO/CSO EpiVax;

Frances Terry, Immunoinformatics / Bioinformatics Specialist, EpiVax, Inc.

Keizo Yoshida Ph.D., EpiVax Asia

 

9: 00 – 9 :45  AM Registration / Breakfast

9: 45 AM              Opening Remarks –  Keizo Yoshida, Ph.D.

10: 00 AM            Immunogenicity: Determinants and Correlates – A. S. De Groot M.D.

11:15 AM –Morning Break – Coffee / Tea

11: 30 AM            Case Studies – Predicting and Confirming Immunogenicity  – A.S. De Groot M.D.

12: 30 PM — Lunch Provided

1: 00 PM              ISPRI Demonstration – Frances Terry, EpiVax

1: 45 PM              iVAX Demonstration Frances Terry, EpiVax

2: 30 PM              Recent Tregitope Data: Application to Protein Medicine – A.S. De Groot M.D

3: 30 PM Afternoon Break – Coffee / Tea

5: 00 PM               FDA and EMEA discussions – Interpreting the guidelines – A.S. De Groot M.D

6: 00 PM               Closing Remarks – Keizo Yoshida, Ph.D., EpiVax Asia

To register for the seminar, contact CMillerIV[at]EpiVax.com or YoshidaKeizo@gmail.com

For more information on Tregitopes, please see this link: http://tinyurl.com/EpiVax-AAPS-Award  and also this link for the original paper: http://tinyurl.com/ASDeGroot-Blood-2008 and here for the relevance to protein medicine: http://tinyurl.com/ASDeGroot-Clin-Immunol-2009